tiprankstipranks
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market
2616
CStone Pharmaceuticals
RESEARCH TOOLSreports

CStone Pharmaceuticals (2616) Revenue

4 Followers
StatisticsMarket CapRevenue

CStone Pharmaceuticals Revenue

CStone Pharmaceuticals had a revenue of 24.73M in the quarter ending Jun 30, 2025, with -83.84%. This bring the company's revenue in the last twelve months to 177.77M, Increased -56.34%. In the fiscal year ending Dec 31, 2024, CStone Pharmaceuticals had annual revenue of 407.20M with -12.21% growth.
Revenue (ttm)
177.77M
Revenue Growth
-55.64%
P/S Ratio
29.73
Revenue/Employee
HK$3,016,333
Employees
135
Market Cap
HK$12.11B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
407.20M-56.64M-12.21%
Dec 31, 2023
463.84M-17.52M-3.64%
Dec 31, 2022
481.36M237.65M+97.51%
Dec 31, 2021
243.72M-795.11M-76.54%
Dec 31, 2020
1.04B―+∞%
Dec 31, 2019
―-12.55M-100.00%
Dec 31, 2018
12.55M2.25M+21.84%
Dec 31, 2017
10.30M――